Find Hexoprenaline manufacturers, exporters & distributors on PharmaCompass

Hexoprenaline

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 1 USDMF, 1 Listed Suppliers

2 API Suppliers
1 USDMF
1 Listed Suppliers

MARKET PLACE

1 APIs

marketPlace
1 APIs

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Gynipral, Bronalin, Etoscol, 32266-10-7, Leanol, 30117-45-4

Molecular Formula

C₂₂H₃₄N₂O₁₀S

Molecular Weight

518.6 g/mol

InChI Key

GTDCHGNGVGRHQY-UHFFFAOYSA-N

FDA UNII

U851S9102C

Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.

1 2D Structure

Hexoprenaline

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

4-[2-[6-[[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]hexylamino]-1-hydroxyethyl]benzene-1,2-diol;sulfuric acid

2.1.2 InChI

InChI=1S/C22H32N2O6.H2O4S/c25-17-7-5-15(11-19(17)27)21(29)13-23-9-3-1-2-4-10-24-14-22(30)16-6-8-18(26)20(28)12-16;1-5(2,3)4/h5-8,11-12,21-30H,1-4,9-10,13-14H2;(H2,1,2,3,4)

2.1.3 InChI Key

GTDCHGNGVGRHQY-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1=CC(=C(C=C1C(CNCCCCCCNCC(C2=CC(=C(C=C2)O)O)O)O)O)O.OS(=O)(=O)O

2.2 Other Identifiers

2.2.1 UNII

U851S9102C

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Ginipral

2. Gynipral

3. Hexoprenaline

4. Ipradol

5. St 1512

6. St-1512

7. St1512

8. Sulfate, Hexoprenaline

2.3.2 Depositor-Supplied Synonyms

1. Gynipral

2. Bronalin

3. Etoscol

4. 32266-10-7

5. Leanol

6. 30117-45-4

7. Delaprem

8. Hexoprenaline Sulphate

9. Nsc-292266

10. St1512/so4

11. 4,4'-[hexane-1,6-diylbis[imino(1-hydroxyethylene)]]dipyrocatechol Sulphate

12. Dsstox_cid_26688

13. Dsstox_rid_81822

14. Dsstox_gsid_46688

15. Hexoprenaline Sulfate (usan)

16. Hexoprenalinesulphate

17. Hexoprenaline Sulfate [usan]

18. 4,4'-(hexane-1,6-diylbis(imino(1-hydroxyethylene)))dipyrocatechol Sulphate

19. 4-[2-[6-[[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]hexylamino]-1-hydroxyethyl]benzene-1,2-diol;sulfuric Acid

20. Cas-32266-10-7

21. U851s9102c

22. Ncgc00167522-01

23. Delaprem (tn)

24. Einecs 250-057-2

25. 1,2-benzenediol, 4,4'-(1,6-hexanediylbis(imino(1-hydroxy-2,1-ethanediyl)))bis-, Sulfate (1:1) (salt)

26. Schembl598186

27. Chembl2104813

28. Dtxsid6046688

29. Chebi:31670

30. Hexoprenaline Sulfate [mi]

31. Hexoprenaline Sulfate [jan]

32. St-1512/so4

33. Tox21_112519

34. Nsc292266

35. Hexoprenaline Sulfate [mart.]

36. Hexoprenaline Sulfate [who-dd]

37. Tox21_112519_1

38. Ncgc00167522-02

39. D02396

40. Q27290818

41. 1, 4,4'-[1,6-hexanediylbis[imino(1-hydroxy-2,1-ethanediyl)]]bis-, Sulfate (1:1) (salt)

42. (+/-)-.alpha.,.alpha.'-(hexamethylenebis(iminomethylene))bis(3,4-dihydroxybenzyl Alcohol) Sulfate (1:1) (salt)

43. (+/-)-.alpha.,.alpha.'-(hexamethylenebis(iminomethylene))bis(3,4-dihydroxybenzyl Alcohol) Sulphate (1:1) (salt)

44. 1,2-benzenediol, 4,4'-(1,6-hexanediylbis(imino(1-hydroxy-2,1-ethanediyl)))bis-, Sulphate (1:1) (salt)

2.4 Create Date

2005-03-26

3 Chemical and Physical Properties

Molecular Formula	C₂₂H₃₄N₂O₁₀S
Molecular Weight	518.6 g/mol
Hydrogen Bond Donor Count	10
Hydrogen Bond Acceptor Count	12
Rotatable Bond Count	13
Exact Mass	518.19341646 g/mol
Monoisotopic Mass	518.19341646 g/mol
Topological Polar Surface Area	228 Å²
Heavy Atom Count	35
Formal Charge	0
Complexity	499
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	2
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Bronchodilator Agents

Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)

Adrenergic beta-2 Receptor Agonists

Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)

Tocolytic Agents

Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)

API SUPPLIERS